Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Green Cap Health vs Maves

Green Cap Health
Graded #258

Lower grade

vs+8.599999999999994
Maves
Graded #89

Higher grade

The verdict

Maves takes it — 71.8/100 to 63.2/100.

Maves grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Maves, operating under parent company Homera Health, is a performance-framed telehealth platform offering compounded semaglutide and tirzepatide for weight loss plus sermorelin for anti-aging, with…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMaves +10
74
84
Dose & formulationMaves +1
64
65
Clinical oversightMaves +8
68
76
Labs & monitoringEven
52
52
FulfillmentMaves +31
56
87
Contract termsMaves +8
47
55
Green Cap Health · left barMaves · right bar

The numbers

MetricGreen Cap HealthMaves
WeighScore63.2/10071.8/100
GradeCC
Scorecard rank#258#89
Semaglutide$129/mo (6-month plan, compounded)$99/mo (starting dose, first-month rate, compounded)
Tirzepatide$199/mo (6-month plan, compounded)Not disclosed
Coverage1 stateAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Green Cap Health

Graded #258 · C

Strengths

  • Vertically integrated: the prescribing practice and the compounding pharmacy are the same company, so the supply chain is short and named
  • Same-day provider review and 1-3 day discreet shipping
  • The full commitment ladder is published, so the month-to-month rate and the six-month rate can be compared directly

Where it loses points

  • The advertised $2.63-a-day and $79 first-month figures do not correspond to any purchasable plan; the cheapest real rates are $129/mo semaglutide and $199/mo tirzepatide, both on six-month commitments, and month-to-month is $179 and $279
  • The terms disclose a separate Weight Management Program Membership Fee, charged periodically on top of the plan and revealed only during checkout — it appears on no product page
  • The terms also state recurring fees are charged in advance without seeking any additional authorisation
  • Service is Texas-only, so nothing here is available to a reader outside that state
  • The site's terms link out to lifemd.com's terms — the legal text is another company's
Maves

Graded #89 · C

Strengths

  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer
  • $99/mo first-month intro pricing on semaglutide — among the most aggressive we track
  • All 50 states covered, stated explicitly
  • Both brand (Maves) and parent (Homera Health) disclosed for accountability

Where it loses points

  • 503A pharmacy partner not named (only 'licensed U.S. pharmacies')
  • Tirzepatide pricing not stated on the homepage — only listed as an offering
  • Named medical director / clinical leadership not disclosed
  • Refund and cancellation policy not detailed publicly
  • Corporate address and arbitration venue not disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard